ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,593Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 676

$744K Total Retail Price of All Prescriptions

Rank: 112 out of 676

505 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

34% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 11,360 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,013 602 S3 1 1
FUROSEMIDE 552 488 2 4
LISINOPRIL 472 367 3 5
OMEPRAZOLE 468 296 4 2
MELOXICAM 379 313 5 13
PRAVASTATIN SODIUM 354 259 6 11
LEVOTHYROXINE SODIUM 334 273 7 7
AMLODIPINE BESYLATE 333 239 8 3
ZOLPIDEM TARTRATE 326 166 9 21
METFORMIN HCL 320 225 10 8
CARVEDILOL 308 262 11 15
GABAPENTIN 301 193 12 10
POTASSIUM CHLORIDE 271 225 13 9
ALLOPURINOL 269 230 14 31
HYDROCHLOROTHIAZIDE 248 199 15 12
TAMSULOSIN HCL 206 171 16 38
DONEPEZIL HCL 205 204 17 24
SIMVASTATIN 204 183 18 6
LOVASTATIN 202 172 19 33
CITALOPRAM HBR 202 146 19 17
WARFARIN SODIUM 195 130 21 18
METOPROLOL TARTRATE 189 145 22 22
CLONIDINE HCL 188 137 23 32
AMLODIPINE BESYLATE-BENAZEPRIL 179 179 24 44
GLIMEPIRIDE 176 130 25 30
CLOPIDOGREL 173 154 26 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 107 27 16
FAMOTIDINE 167 121 28 64
PLAVIX 157 128 29 40
GLIPIZIDE ER 139 104 30 103
ATORVASTATIN CALCIUM 133 104 31 20
ATENOLOL 131 92 32 25
DIOVAN 126 90 33 37
NEXIUM 122 63 34 23
NAMENDA 115 115 35 35
METOPROLOL SUCCINATE 115 93 35 14
FLUTICASONE PROPIONATE 114 63 37 49
CYCLOBENZAPRINE HCL 96 50 R 38 50
SINGULAIR 93 60 39 80
SERTRALINE HCL 92 91 40 26
DIOVAN HCT 83 59 41 41
LANTUS 83 57 41 55
PAROXETINE HCL 82 74 43 65
PANTOPRAZOLE SODIUM 81 59 44 42
DIGOXIN 81 69 44 52
RISPERIDONE 78 78 46 69
ESCITALOPRAM OXALATE 78 49 46 73
RAMIPRIL 72 52 48 86
CYMBALTA 67 20 49 47
COMBIVENT 66 51 50 174
VENLAFAXINE HCL ER 63 0 51 98
RANITIDINE HCL 63 63 51 27
LYRICA 62 18 53 57
MECLIZINE HCL 61 42 54 83
SPIRONOLACTONE 61 61 54 62
SYNTHROID 60 48 56 48
ISOSORBIDE MONONITRATE ER 60 48 56 54
VERAPAMIL ER 60 47 56 101
CEPHALEXIN 59 36 59 84
LANSOPRAZOLE 58 45 60 171
KLOR-CON M20 57 57 61 67
CIPROFLOXACIN HCL 57 42 61 45
TRAZODONE HCL 53 44 63 36
BUSPIRONE HCL 53 38 63 113
TIZANIDINE HCL 50 0 65 68
AMITRIPTYLINE HCL 50 28 R 65 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.